2714315-25-8
2714315-25-8
Chemical Structure
Balsalazide-d4
- CAS No.: 2714315-25-8
- Formula:C17H11D4N3O6
- Molecular Weight:361.34
IUPAC Name: (E)-5-((4-((2-carboxyethyl)carbamoyl)phenyl-2,3,5,6-d4)diazenyl)-2-hydroxybenzoic acid
InChIKey: IPOKCKJONYRRHP-AAMHWJAJSA-N
SMILES: O=C(O)C1=CC(/N=N/C2=C([2H])C([2H])=C(C(NCCC(O)=O)=O)C([2H])=C2[2H])=CC=C1O
Biological Activity: Balsalazide-d4 is deuterium labeled Balsalazide. Balsalazide could suppress colitis-associated carcinogenesis through modulation of IL-6/STAT3 pathway.
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Balsalazide-d4 | 99.9% | Balsalazide-d4 is deuterium labeled Balsalazide. Balsalazide could suppress colitis-associated carcinogenesis through modulation of IL-6/STAT3 pathway. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Balsalazide-d3 | Balsalazide-d3 is the deuterium labeled Balsalazide (HY-B0667). Balsalazide is a prodrug of amino salicylic acid that releases mesalamine (HY-15027) in the colon, offering various anti-inflammatory effects in areas of colitis, and it also exerts related anticancer effects by regulating the IL-6/STAT3 pathway. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Balsalazide | 98.65% | Balsalazide is a prodrug of amino salicylic acid that releases mesalamine (HY-15027) in the colon, offering various anti-inflammatory effects in areas of colitis, and it also exerts related anticancer effects by regulating the IL-6/STAT3 pathway. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
